Plasma YKL-40 as a Biomarker for Bevacizumab Efficacy in Patients With Newly Diagnosed Glioblastoma in the Phase 3 Randomized AVAglio Trial

Oncotarget- United States

doi 10.18632/oncotarget.22886

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Publisher

Impact Journals, LLC

Related search

A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma

Archives of Neurology
2010English

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Role of Interlekin-35 as a Biomarker in Patients With Newly Diagnosed Hashimoto’s Thyroiditis

Endocrine Regulations
EndocrinologyMetabolismDiabetes
2016English

Controversies in the Treatment of Elderly Patients With Newly Diagnosed Glioblastoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Randomized Trial of a Presurgical Scheduled Reduced Smoking Intervention for Patients Newly Diagnosed With Cancer.

Health Psychology
MedicinePsychiatryMental HealthApplied Psychology
2014English

A Budget Impact Model for the Introduction of Bevacizumab for the Treatment of Newly Diagnosed Glioblastoma Multiforme in the UK

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Heat Shock Protein Peptide Complex-96 Vaccination for Newly Diagnosed Glioblastoma: A Phase I, Single-Arm Trial

JCI insight
Medicine
2018English

RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2013English

Single Dose Bevacizumab as Treatment for Symptomatic, Corticosteroid-Refractory Pseudoprogression After Chemoradiation Therapy for Newly Diagnosed Glioblastoma: A Case Report

Integrative Cancer Science and Therapeutics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy